Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01515189
Brief Title: Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab

First Submitted : January 18, 2012
First Submitted that Met QC Criteria : January 18, 2012
First Posted : January 24, 2012 (Estimate)

Results First Submitted : February 3, 2017
Results First Submitted that Met QC Criteria : February 3, 2017
Results First Posted : March 24, 2017

Last Update Submitted that Met QC Criteria : July 29, 2019
Last Update Posted : July 31, 2019